课题基金 / 基金详情

项目摘要

项目成果

Carole Bewley的其他基金

相似基金

相关文献

中文摘要
翻译
自然产物化学科,LBC,NIDDK有几个正在进行的项目,其长期目标是识别和设计HIV-1包膜介导的细胞融合的抑制剂和探针。这些包括设计和开发新的gp41衍生的具有抑制和免疫原双重功能的多肽和蛋白质,发现和高分辨结构表征新的碳水化合物结合蛋白,通过糖与gp120/gp41的相互作用有效地抑制HIV-1进入,发现HIV-1融合的天然产物抑制剂,以及HIV-1包膜-辅助受体相互作用的结构和机制研究。
英文摘要
The Natural Products Chemistry Section, LBC, NIDDK has several ongoing projects whose long term aim is to identify and design inhibitors and probes of HIV-1 Envelope-mediated cell fusion. These include the design and development of new gp41-derived peptides and proteins that have dual functions as inhibitors and immunogens, discovery and high resolution structural characterization of new carbohydrate binding proteins that potently inhibit HIV-1 Entry through carbohydrate-mediated interactions with gp120/gp41, discovery of natural product inhibitors of HIV-1 fusion, and structural and mechanistic studies of HIV-1 Envelope - coreceptor interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of Natural Products and Natural Product-Like Inhibitors
NMR Facility Management and Application of NMR Spectroscopy
Discovery of Natural Products and Natural Product-Like Inhibitors
Inhibitors and Probes of HIV-1 Cell Fusion
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究